메뉴 건너뛰기




Volumn 89, Issue 3, 2004, Pages 1213-1216

Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: Results of a prospective study

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN C;

EID: 12144287600     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031595     Document Type: Article
Times cited : (10)

References (25)
  • 1
    • 0032952176 scopus 로고    scopus 로고
    • Neuroendocrine control of growth hormone secretion
    • Muller EE, Locatelli V, Cocchi D 1999 Neuroendocrine control of growth hormone secretion. Physiol Rev 79:511-607
    • (1999) Physiol Rev , vol.79 , pp. 511-607
    • Muller, E.E.1    Locatelli, V.2    Cocchi, D.3
  • 2
    • 0032239547 scopus 로고    scopus 로고
    • Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
    • Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
    • (1998) Endocr Rev , vol.19 , pp. 717-797
    • Giustina, A.1    Veldhuis, J.D.2
  • 3
    • 0027300526 scopus 로고
    • Postsomatostatin hypersecretion of growth hormone from perifused rat anterior pituitary cells is dependent on calcium influx
    • McFarlane MB, Bruhn TO, Jackson IM 1993 Postsomatostatin hypersecretion of growth hormone from perifused rat anterior pituitary cells is dependent on calcium influx. Neuroendocrinology 57:496-502
    • (1993) Neuroendocrinology , vol.57 , pp. 496-502
    • McFarlane, M.B.1    Bruhn, T.O.2    Jackson, I.M.3
  • 4
    • 0033568862 scopus 로고    scopus 로고
    • Expression of Ca(2+)-mobilizing endothelin(A) receptors and their role in the control of Ca(2+) influx and growth hormone secretion in pituitary somatotrophs
    • Tomic M, Zivadinovic D, Van Goor F, Yuan D, Koshimizu T, Stojilkovic SS 1999 Expression of Ca(2+)-mobilizing endothelin(A) receptors and their role in the control of Ca(2+) influx and growth hormone secretion in pituitary somatotrophs. J Neurosci 15:7721-7731
    • (1999) J Neurosci , vol.15 , pp. 7721-7731
    • Tomic, M.1    Zivadinovic, D.2    Van Goor, F.3    Yuan, D.4    Koshimizu, T.5    Stojilkovic, S.S.6
  • 5
    • 0033837789 scopus 로고    scopus 로고
    • Diverse intracellular signalling systems used by growth hormone-releasing hormone in regulating voltage-gated Ca2+ or K channels in pituitary somatotropes
    • Chen C, Xu R, Clarke IJ, Ruan M, Loneragan K, Roh SG 2000 Diverse intracellular signalling systems used by growth hormone-releasing hormone in regulating voltage-gated Ca2+ or K channels in pituitary somatotropes. Immunol Cell Biol 78:356-368
    • (2000) Immunol Cell Biol , vol.78 , pp. 356-368
    • Chen, C.1    Xu, R.2    Clarke, I.J.3    Ruan, M.4    Loneragan, K.5    Roh, S.G.6
  • 6
    • 0242504299 scopus 로고
    • Dihydropyridine Ca2+ antagonists: Potent inhibitors of secretion from normal and transformed pituitary cells
    • Enyeart JJ, Aizawa T, Hinkle PM 1985 Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells. Am J Physiol 248:C510-C519
    • (1985) Am J Physiol , vol.248
    • Enyeart, J.J.1    Aizawa, T.2    Hinkle, P.M.3
  • 7
    • 0024202044 scopus 로고    scopus 로고
    • Release of growth hormone from purified somatotrophs: Effect of the calcium channel antagonists diltiazem and nifedipine on release induced by growth hormone-releasing factor
    • Lussier BT, Moor BC, French MB, Kraicer J 1998 Release of growth hormone from purified somatotrophs: effect of the calcium channel antagonists diltiazem and nifedipine on release induced by growth hormone-releasing factor. Can J Physiol Pharmacol 66:1373-1380
    • (1998) Can J Physiol Pharmacol , vol.66 , pp. 1373-1380
    • Lussier, B.T.1    Moor, B.C.2    French, M.B.3    Kraicer, J.4
  • 8
    • 0025774661 scopus 로고
    • Inhibition by nimodipine of growth hormone (GH) releasing factor-induced GH secretion from rat anterior pituitary cells
    • Kato M, Suzuki M 1991 Inhibition by nimodipine of growth hormone (GH) releasing factor-induced GH secretion from rat anterior pituitary cells. Jpn J Physiol 41:63-74
    • (1991) Jpn J Physiol , vol.41 , pp. 63-74
    • Kato, M.1    Suzuki, M.2
  • 9
    • 0018829296 scopus 로고
    • Inhibition of anterior pituitary hormone release by infusion of calcium chloride in the rat
    • Sowers JR, Walker S, Sollars E, Herzog J 1980 Inhibition of anterior pituitary hormone release by infusion of calcium chloride in the rat. Endocrinology 106:1809-1814
    • (1980) Endocrinology , vol.106 , pp. 1809-1814
    • Sowers, J.R.1    Walker, S.2    Sollars, E.3    Herzog, J.4
  • 10
    • 0016236373 scopus 로고
    • Stability of secretory granules containing growth hormone and prolactin from bovine anterior pituitary gland
    • Lemay A, Labrie F, Drouin D 1974 Stability of secretory granules containing growth hormone and prolactin from bovine anterior pituitary gland. Can J Biochem 52:327-335
    • (1974) Can J Biochem , vol.52 , pp. 327-335
    • Lemay, A.1    Labrie, F.2    Drouin, D.3
  • 11
    • 0015218975 scopus 로고
    • Adenosine 3′,5′-monophosphate-dependent protein kinase from bovine anterior pituitary gland. I. Properties
    • Labrie F, Lemaire S, Courte C 1971 Adenosine 3′,5′- monophosphate-dependent protein kinase from bovine anterior pituitary gland. I. Properties. J Biol Chem 246:7293-7302
    • (1971) J Biol Chem , vol.246 , pp. 7293-7302
    • Labrie, F.1    Lemaire, S.2    Courte, C.3
  • 12
    • 0036155808 scopus 로고    scopus 로고
    • Cell-type specific messenger functions of extracellular calcium in the anterior pituitary
    • Zivadinovic D, Tomic M, Yuan D, Stojilkovic SS 2002 Cell-type specific messenger functions of extracellular calcium in the anterior pituitary. Endocrinology 143:445-455
    • (2002) Endocrinology , vol.143 , pp. 445-455
    • Zivadinovic, D.1    Tomic, M.2    Yuan, D.3    Stojilkovic, S.S.4
  • 17
    • 1642293936 scopus 로고    scopus 로고
    • Evaluation of growth disorders in the paediatric clinic
    • Cappa M, Loche S 2003 Evaluation of growth disorders in the paediatric clinic. J Endocrinol Invest 26(7 Suppl):54-63
    • (2003) J Endocrinol Invest , vol.26 , Issue.7 SUPPL. , pp. 54-63
    • Cappa, M.1    Loche, S.2
  • 18
    • 0031753015 scopus 로고    scopus 로고
    • Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine provocative tests for the diagnosis of GH deficiency in adults
    • Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E 1998 Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615-1618
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 1615-1618
    • Aimaretti, G.1    Corneli, G.2    Razzore, P.3    Bellone, S.4    Baffoni, C.5    Arvat, E.6    Camanni, F.7    Ghigo, E.8
  • 19
    • 0028700420 scopus 로고
    • The reaction of adenohypophysis hormones in primary hyperparathyroidism and after surgical treatment
    • Kovacs L, Szilagyi G, Szabolcs I, Goth M 1994 The reaction of adenohypophysis hormones in primary hyperparathyroidism and after surgical treatment. Acta Med Hung 2:15-21
    • (1994) Acta Med Hung , vol.2 , pp. 15-21
    • Kovacs, L.1    Szilagyi, G.2    Szabolcs, I.3    Goth, M.4
  • 20
    • 0020601451 scopus 로고
    • Growth hormone, prolactin and insulin following arginine infusion in primary hyperparathyroidism before and after parathyroidectomy
    • Copenh
    • Schernthaner G, Kovarik J, Prager R, Willvonseder R 1983 Growth hormone, prolactin and insulin following arginine infusion in primary hyperparathyroidism before and after parathyroidectomy. Acta Endocrinol (Copenh) 104: 206-209
    • (1983) Acta Endocrinol , vol.104 , pp. 206-209
    • Schernthaner, G.1    Kovarik, J.2    Prager, R.3    Willvonseder, R.4
  • 21
    • 0042024921 scopus 로고    scopus 로고
    • Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity
    • Jansen JA, van der Lely AJ, Lamberts SW 2003 Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity. J Endocrinol Invest 26:588-594
    • (2003) J Endocrinol Invest , vol.26 , pp. 588-594
    • Jansen, J.A.1    Van Der Lely, A.J.2    Lamberts, S.W.3
  • 22
    • 0033346804 scopus 로고    scopus 로고
    • Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: Comparison with insulin-induced hypoglycemia test
    • Gasperi M, Aimaretti G, Scarcello G, Corneli G, Cosci C, Arvat E, Martino E, Ghigo E 1999 Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. J Clin Endocrinol Metab 84:2633-2637
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 2633-2637
    • Gasperi, M.1    Aimaretti, G.2    Scarcello, G.3    Corneli, G.4    Cosci, C.5    Arvat, E.6    Martino, E.7    Ghigo, E.8
  • 23
    • 0034700450 scopus 로고    scopus 로고
    • Hyperparathyroid and hypoparathyroid disorders
    • Marx SJ 2000 Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863-1875
    • (2000) N Engl J Med , vol.343 , pp. 1863-1875
    • Marx, S.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.